Wells Fargo & Company Cryo Cell International Inc Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$4.19 - $6.6 $8 - $13	2 Added 7.41%	29 $0
Q3 2023 Nov 13, 2023	BUY	$5.03 - $7.04 $10 - $14	2 Added 8.0%	27 $0
Q1 2023 May 12, 2023	BUY	$2.97 - $4.66 $2 - $4	1 Added 4.17%	25 $0
Q4 2022 Feb 13, 2023	BUY	$4.12 - $5.22 $4 - $5	1 Added 4.35%	24 $0
Q3 2022 Nov 14, 2022	BUY	$5.2 - $7.53 $26 - $37	5 Added 27.78%	23 $0
Q2 2022 Aug 12, 2022	SELL	$5.83 - $7.71 $2,909 - $3,847	-499 Reduced 96.52%	18 $0
Q1 2022 May 16, 2022	BUY	$7.28 - $11.84 $3,640 - $5,920	500 Added 2941.18%	517 $4,000
Q4 2021 Feb 14, 2022	SELL	$11.27 - $13.9 $5,443 - $6,713	-483 Reduced 96.6%	17 $0
Q3 2021 Nov 15, 2021	BUY	$8.97 - $14.16 $4,485 - $7,080	500 New	500 $6,000

916K

Ticker CCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 8,519,250
Market Cap $54.8M
Description
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.